IL6 and osteosarcoma: In osteosarcoma, irisin reversed interleukin-6 (IL-6)-induced EMT, leading to a reduction in N-cadherin, vimentin, fibronectin, MMP2, MMP6, and MMP9 expression, alongside STAT3/Snail suppression [50].